Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


1 June Marks Historic Day For Patent Protection In Europe

Executive Summary

The forthcoming unitary patent system and Unified Patent Court promise to make applying for patents in Europe and litigating infringements simpler and less costly for applicants.

You may also be interested in...

‘Deeply Troubling’ – Pharma Industry's Verdict On EU Compulsory Licensing Plan

The European Commission’s plans for an EU-wide compulsory licensing mechanism have drawn a wide range of responses, with some stakeholders wanting the whole idea dropped and others applauding it and calling for the mechanism to be used outside health emergency situations too.

EU’s New Unitary Patent Proves Popular, Albeit With A High Opt-Out Rate

The European Patent Office has reported a steady flow of requests for unitary patents since the new system was introduced in June, with more than 1,100 applications in the “health” sector. But many patentees are choosing not to take part, with some estimates putting the number of patents opted out of the system at half a million so far.

EU CHMP Opinions And MAA Updates

This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the EU, and updates on EU marketing authorization changes recommended by the CHMP.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts